CDAK
Closed
Codiak Biosciences inc
0.009
-0.003 (-24.79%)
Last Update: 07 Jun 2023 16:30:00
Yesterday: 0.0121
Day's Range: 0.009 - 0.0146
Send
sign up or login to leave a comment!
When Written:
0.1745
Codiak BioSciences Inc is a clinical-stage biopharmaceutical company focused on developing exosome-based therapeutics for the treatment of various diseases. The company's proprietary exosome technology platform enables the development of targeted therapies that can deliver therapeutic payloads to specific cells and tissues. Codiak's lead product candidate, exoASO-STAT6, is being developed for the treatment of allergic conjunctivitis and has shown promising results in preclinical studies. The company also has several other programs in preclinical development, including exosome-based therapies for cancer and neurodegenerative diseases. Codiak was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








